logo BDSP

Base documentaire


  1. Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer : Prostate-specific antigen : the best prostatic tumor marker.

    Fascicule - En anglais

    The serum prostate-specific antigen level, digital rectal examination findings, and Gleason score from the biopsy have been shown to predict the likelihood of metastatic disease in patients with newly diagnosed adenocarcinoma of the prostate.

    Several authors have suggested that using PSA in conjunction with local clinical stage and tumor grade can eliminate the need for staging CT scans, MR imaging scans, pedal lymphangiography, and pelvic lymph-node dissection in many patients with newly diagnosed prostate cancer.

    The purpose of this article is to review the literature on this subject.

    Mots-clés Pascal : Adénocarcinome, Prostate, Marqueur tumoral, Antigène spécifique prostate, Classification par stade, Intérêt, Tomodensitométrie, Imagerie RMN, Lymphographie, Exploration clinique, Spécificité, Coût, Efficacité, Etude comparative, Homme, Tumeur maligne, Appareil urinaire pathologie, Appareil génital mâle pathologie, Prostate pathologie, Biologie, Radiodiagnostic, Imagerie médicale, Economie santé

    Mots-clés Pascal anglais : Adenocarcinoma, Prostate, Tumoral marker, Prostate specific antigen, Stage classification, Interest, Computerized axial tomography, Nuclear magnetic resonance imaging, Lymphography, Clinical investigation, Specificity, Costs, Efficiency, Comparative study, Human, Malignant tumor, Urinary system disease, Male genital diseases, Prostate disease, Biology, Radiodiagnosis, Medical imagery, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0288276

    Code Inist : 002B14D02. Création : 15/07/1997.